|
|
|
|
|
|
|
PEER-TO-PEER CLINICAL CONVERSATIONS |
|
|
|
|
|
| Mental Health and Prostate Cancer in the Veterans Population |
Zachary Klaassen, MD, MSc
Alicia Morgans speaks with Zach Klaassen about his research focusing on the intersection of mental health and prostate cancer care in the veterans’ population. Dr. Klaassen shares insights from his extensive study aimed at creating the world's largest prostate cancer mental health database. |
|
|
|
|
|
|
|
|
|
|
| How Mental Health Disorders Impact Treatment Decisions in Localized Prostate Cancer |
|
Joshua Cabral, MD, and Yaw Nyame, MD, MS, MBA Ruchika Talwar hosts Joshua Cabral and Yaw Nyame to explore the impact of mental health disorders on prostate cancer care. Their study, "Inequities in Definitive Treatment for Localized Prostate Cancer Among Those With Clinically Significant Mental Health Disorders," used the Medicare database from 2004 to 2015.
|
|
|
|
|
|
|
|
|
|
|
| Mental Health Illness in Patients with Non-Muscle Invasive Bladder Cancer. Does BCG Play a Role? |
| Valentina Grajales, MD, MS |
| Ruchika Talwar spotlights the crucial research of Valentina Grajales. Driven by a personal experience with her father's prostate cancer diagnosis and consequent depression, Dr. Grajales explores the incidence of mental health illness in non-muscle invasive bladder cancer patients. |
|
|
|
|
|
|
|
|
|
|
|
| Impact of Mental Health Illness Prior to Prostate Cancer Diagnosis on Treatment Received and Prostate Cancer Outcomes
|
| Zachary Klaassen, MD, MSc
|
| Zachary Klaassen presents a study on the impact of mental health illness (MHI) prior to prostate cancer diagnosis on treatment and outcomes. The analysis of 52,407 male veterans revealed that men with MHI were more likely to receive definitive therapy and had higher biochemical recurrence rates post-treatment. Although adherence to surveillance was slightly lower in the MHI group, the findings highlight the need for targeted interventions to improve post-treatment outcomes for these patients.
|
|
|
|
|
|
| Smoking Status is Associated with Poor Mental Health in Bladder Cancer Patients and Survivors
|
| Khalid Alkhatib, MD, MMSc
|
| Khalid Alkhatib presents a study analyzing the association between smoking status and mental health in bladder cancer patients using data from the CDC National Behavioral Risk Factor Surveillance System. The study found that current smokers with bladder cancer were more likely to experience poor mental health compared to non-smokers, while former smokers did not show a significant association
|
|
|
|
|
|
|
|
|
|
|
| Mental Health Changes in Patients Undergoing Radical Cystectomy with Urinary Diversion
|
| Pushan Prabhakar, MBBS, MPH
|
| Pushan Prabhakar presents a study on mental health changes in patients undergoing radical cystectomy with urinary diversion. The study used the Beck Depression Inventory-II (BDI-II) to assess depression levels pre-surgery, and at 6 weeks, 3 months, and 6 months post-surgery. Dr. Prabhakar emphasized the importance of providing effective counseling and support during the immediate post-operative period when depression scores are highest.
|
|
|
|
|
|
| European Urology Oncology Lecture: Survivorship Considerations Across the Spectrum of Genitourinary Oncology |
| Alicia K. Morgans, MD, MPH |
| Alicia Morgans discusses survivorship considerations for genitourinary oncology patients, emphasizing the importance of comprehensive care that begins at diagnosis and extends through the patient's life. She highlights key aspects such as cardio-oncology, mental health, and sexual health, stressing the need for multidisciplinary approaches to address complications and improve quality of life. |
|
|
|
|
|
| Survivorship Issues Beyond 2 Years After Treatment in Testicular Germ Cell Tumors: Experience from a Large Center in the United Kingdom
|
| Jonathan Shamash, MB, ChB |
| Jonathan Shamash presented findings from a UK study on long-term survivorship issues in testicular germ cell tumor patients beyond two years post-treatment. The analysis of 721 patients revealed that relapse rates were low after two years, but survivorship issues such as endocrinologic and fertility problems persisted consistently from years 3 to 10, especially in those who received adjuvant or metastatic treatment.
|
|
|
|
|
|
| The Importance of a Prostate Cancer Survivorship Program: A Multi-Disciplinary Approach
|
| Zachary Klaassen, MD, MSc and Sherita A. King, MD |
| Despite prostate cancer being the second most common cause of cancer mortality among American men,1 there are over 3 million men in the United States living with prostate cancer. As such, there are many “prostate cancer survivors” that are either on active surveillance/watchful waiting or have undergone treatment for localized or advanced disease. |
|
|
|
|
|
|
|
|
|
|
